基于病灶直径简化分割的病理注册影像组学评估临床显著前列腺癌:多阅片者研究
本研究为单中心回顾性研究,纳入175例接受双参数MRI的参与者(120例根治性前列腺切除,55例对照),利用全 mount 病理注册生成病灶级金标准,并由6名放射科医师按PI-RADS v2.1标记病灶直径后自动生成简化分割,构建10特征病理衍生影像组学签名。结果显示该签名单独诊断csPCa的AUC为0.66,与PSAD联合后AUC提升至0.75,接近PI-RADS+PSAD模型的0.77。
要点
- 病理注册影像组学签名联合PSAD可提升csPCa诊断效能,AUC达0.75。
- 简化分割(基于病灶直径的圆形分割)可行,无需复杂手动勾画。
- PI-RADS+PSAD模型绝对准确率最高(74%),但联合签名模型接近。
局限性
- 单中心回顾性研究,样本量有限。
- 简化分割可能丢失病灶异质性信息。
- 需外部验证确认泛化能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To develop a pathology-derived radiomics signature for detecting clinically significant prostate cancer (csPCa) and to evaluate its performance using lesion diameter-based simplified segmentations.
MATERIALS AND METHODS: In this retrospective single-center study, 175 participants (120 radical prostatectomy cases; 55 controls) underwent biparametric MRI during 2013-2022. Whole-mount histopathology was registered to MRI using a patient-specific, mold-based 3D pipeline to generate lesion-level ground truth. Six radiologists from different institutions marked lesion diameters per Prostate Imaging Reporting & Data System (PI-RADS) v2.1, blinded to pathology; automated circular segmentations were generated from these measurements and expanded (±1 slice). Features (PyRadiomics) were preprocessed, filtered, and benchmarked via nested cross-validation. Recursive feature elimination produced a 10-feature pathology-derived radiomics signature. Models (Signature, prostate-specific antigen density [PSAD], PI-RADS, and their combinations) were trained/evaluated using a soft-voting ensemble (logistic regression, random forest, and XGBoost) with patient-level grouping; thresholds were optimized using Youden's J. DeLong's and McNemar's tests were used for model comparisons.
RESULTS: PSAD+Signature achieved 0.75 area under the curve (AUC) and 68% (211/312) accuracy. PI-RADS+PSAD achieved 0.77 AUC and 74% (230/312) accuracy. Signature-only achieved 0.66 AUC and 62% (194/312) accuracy. A higher AUC for PSAD+Signature versus Signature (|ΔAUC|=0.093, p=0.012) and for the tripartite model versus Signature (|ΔAUC| = 0.11, p=0.007) was found. PSAD+Signature and PI-RADS+PSAD had similar accuracy (p=0.06).
CONCLUSION: A histopathology-trained radiomics signature demonstrated moderate standalone performance for lesion-level csPCa detection. When combined with PSAD, diagnostic performance improved and approached that of PI-RADS+PSAD, which achieved the highest absolute accuracy. The PSAD+Signature framework offers a simplified, spatially localized approach that may complement existing PI-RADS-based assessment while maintaining low implementation complexity.
引用
- Esengur OT, Harmon SA, Gelikman DG, et al. Evaluating Clinically Significant Prostate Cancer with Pathology-Registered Radiomics: A Multi-Reader Assessment Using Lesion Diameter-based Simplified Segmentations on MRI. Acad Radiol. 2026. PMID: 42049617. doi:10.1016/j.acra.2026.04.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。